BiGEN
VC Fund
Seoul, South Korea
BiGEN is a biotech company with the goal of providing qualified medicinal products.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries BiGEN invests in
Stages BiGEN invests in
Countries BiGEN invests in
Investment Focus
Industry
- Biotechnology 2 (50%)
- Medical 1 (25%)
- App Discovery 1 (25%)
- Product Research 1 (25%)
- Contact Management 1 (25%)
Stage
- Funding Round 3 (75%)
- Series C 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Noile-Immune Biotech
|
Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy. | $21.9M / Series C / Mar 22, 2021 | |
Junten Bio
|
JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine. | $1.8M / Dec 17, 2018 | |
|
Noile-Immune Biotech
|
Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy. | $77K / May 31, 2018 | |
Momotaro-Gene
|
Momotaro-Gene is a drug discovery business for commercialization of drug discovery seeds. | $1.4M / Mar 15, 2017 |
Co-Investors
DCI Partners
3 deals together
Sosei CVC
2 deals together
Binex
1 deal together
Dai-ichi Life
1 deal together
Healthcare Innovation
1 deal together
H.U. Group Central Research Institute
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does BiGEN invest in?
BiGEN invests primarily in Biotechnology, Medical and App Discovery startups, most often at Funding Round and Series C stage. Most of the 4 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did BiGEN last invest?
The most recent investment recorded for BiGEN closed in Mar 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
